Skip to content
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
Search
Join Pα+
  • My Pα+
  • Sign In
Menu
  • My Pα+
  • Sign In
Pα+
  • My Pα+
  • Sign In
  • My Pα+
  • Sign In
Search
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
Read more about the article GreenStar Biosciences Announces New Provisional Patent Application

GreenStar Biosciences Announces New Provisional Patent Application

  • Post published:September 14, 2020
  • Post category:Press Release
Read more about the article GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences

GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences

  • Post published:July 23, 2020
  • Post category:Press Release
Read more about the article GreenStar Biosciences Signs Definitive Agreement to Acquire 100% of Eleusian Biosciences Corp.

GreenStar Biosciences Signs Definitive Agreement to Acquire 100% of Eleusian Biosciences Corp.

  • Post published:July 21, 2020
  • Post category:Press Release
Read more about the article GreenStar Biosciences Signs Agreement to Acquire 100% of Eleusian Biosciences Corp.

GreenStar Biosciences Signs Agreement to Acquire 100% of Eleusian Biosciences Corp.

  • Post published:June 16, 2020
  • Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More